Search Results

Binders, Drugs, and more Discovery of (S)-3-(4-(benzyloxy)phenyl)-2-(2-phenoxyacetamido)propanoic acid for high-throughput gpcrs antibody discovery Reviews, GPCRs, and more Current strategic trends in drug discovery: the present as prologue Industry News Exscientia Business Update for Third Quarter 2023 Addex - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar Discovery Chemistry April 5 - 10, 2024 | AACR Annual Meeting NEW April 22 - 23, 2024 | Endocrine Metabolic

Modulating GPCR and 14-3-3 protein interactions: prospects for CNS drug discovery. GPCR Binders, Drugs, and more Design of Drug Efficacy Guided by Free Energy Simulations of the β2 -Adrenoceptor Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. FREE Symposium - IPI Surfacing (June 15, 2023) NEW GPCRs in drug discovery: challenges & solutions (June

Hello Dr.GPCR readers! This is Lucía from the Celtarys Research chemistry team.  For our very first post in this ecosystem, we wanted to highlight a huge part of our work at Celtarys Research: conjugation strategies. You can check what we do here on our website!   Conjugation strategies for small molecules are very versatile! In this case, we would like to focus on the synthesis of fluorescent probes. Traditionally, the most reliable and commonly used method is the amide coupling  using acid and amine .[ 1 ] This method has several advantages: it is usually very robust, good yields, reagents are found in most chem labs (like HATU, HoBT, EDCI etc.). Still, there are some downsides, such as the byproduct obtained by the O-acylisourea rearranging intramolecularly into the N-acylurea.[ 2]     NHS ester amide coupling  is the most suited for bioconjugation with proteins, DNA, etc, thanks to its reaction with the free amino groups present in these biomolecules. NHS esters are not very stable even in aqueous environment but they only need a slightly basic medium for the reaction to work, so they have to be used quickly and stored correctly. Not only do they work in aqueous medium, but also in aprotic solvents like DMF, where you will need to add a base such as TEA. [ 3]     Maleimide  conjugation with thiols  present Cys residues. This conjugation is very useful for tagging biomolecules and can also be used to develop fluorescent probes with small molecules. Its biggest advantage is the presence of Cys residues in proteins, although sometimes S-S bridge reduction is needed, and how quickly the reaction takes place. The biggest detractor? It’s reversible under non-reducing conditions. [ 4]     Other strategies include click chemistry,  more specifically, the CuAAC (Cu(I)- catalyzed azide-alkyne 1,3-dipolar cycloaddition), which is a very robust conjugation strategy to obtain linkers with a rigid moiety (the triazol). But it also presents some issues, such as synthesizing the as the presence of the copper catalyst, which has to be removed completely, otherwise it can quelate biomolecules or induce cell toxicity. [ 5]     At Celtarys’ we have our conjugation strategy - our own proprietary technology- which bypasses some of the issues seen before. There’s no need for any catalysts; all reagents will be incorporated in the structure of the final compound. The reaction is convergent, efficient and robust. Thanks to the unique linker structure we obtain, which can be divided into three differentiated parts, we can modify the rigidity of the linker as well as the physicochemical properties of the whole probe. This property comes from the wide chemical space this reaction can access – we can substitute one reagent and make an unprecedented combination, also using commercially available precursor, which improves the performance of the probes.  It also poses some disadvantages – just like acid-amine amide coupling, some byproducts are obtained during the synthesis. However, these are usually easily removable. Besides, it’s an eco-friendlier method, which always helps future-proof our probes!  References   (1) Brown, D. G.; Boström, J. Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?: Miniperspective. J. Med. Chem.   2016 , 59  (10), 4443–4458. https://doi.org/10.1021/acs.jmedchem.5b01409 .   (2) Sam, S.; Touahir, L.; Salvador Andresa, J.; Allongue, P.; Chazalviel, J.-N.; Gouget-Laemmel, A. C.; Henry De Villeneuve, C.; Moraillon, A.; Ozanam, F.; Gabouze, N.; Djebbar, S. Semiquantitative Study of the EDC/NHS Activation of Acid Terminal Groups at Modified Porous Silicon Surfaces. Langmuir   2010 , 26  (2), 809–814. https://doi.org/10.1021/la902220a .   (3) Fan, J.; Toth, I.; Stephenson, R. J. Chapter Three - Bioconjugated Materials in the Development of Subunit Vaccines. In Comprehensive Analytical Chemistry ; Verma, S. K., Das, A. K., Eds.; Elsevier, 2023; Vol. 103, pp 59–103. https://doi.org/10.1016/bs.coac.2023.02.005 .   (4) Fontaine, S. D.; Reid, R.; Robinson, L.; Ashley, G. W.; Santi, D. V. Long-Term Stabilization of Maleimide–Thiol Conjugates. Bioconjugate Chem.   2015 , 26  (1), 145–152. https://doi.org/10.1021/bc5005262 .   (5) Meldal, M.; Tornøe, C. W. Cu-Catalyzed Azide−Alkyne Cycloaddition. Chem. Rev.   2008 , 108  (8), 2952–3015. https://doi.org/10.1021/cr0783479 .

October 2022 "Understanding the activation of G protein-coupled receptors (GPCRs) is of paramount importance cardiovascular medicine due to the critical physiological roles of these receptors and their prominence as drug Although many cardiovascular GPCRs have been extensively studied as model receptors for decades, new As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation Read more at the source #DrGPCR #GPCR #IndustryNews

G protein-coupled receptors (GPCRs) are membrane-bound proteins that sense external stimuli and relay While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers Class B1 GPCRs are an important subclass of GPCRs that include 15 receptors involved in regulating body for our understanding of GPCR function and signal transduction. Tate, New insights into GPCR coupling and dimerisation from cryo-EM structures.  

Binders, Drugs, and more Cloning and deorphanization of three inotocin (insect oxytocin/vasopressin-like Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules Respond to Drug-Like Molecules Accurately predicting GPCR P2Y1 membrane protein ligand binding with Associate in Computational Chemistry/Biophysics NEW Post-Doctoral Associate NEW Team Leader Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design and Pharmacology Faculty

Hello GPCR enthusiasts! We're here to share the latest GPCR news with you. Congratulations to Dr. GPCR Newsletter for updates! GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins (March 24 GPCR Ecosystem

GPCR Binders, Drugs, and more Adenosine A2A Receptor (A2AAR) Ligand Screening Using the 19F-NMR Probe GPCRs in Cardiology, Endocrinology, and Taste Discovery of paralogous GnRH and corazonin signaling systems Confo Therapeutics Enters Into Research Collaboration For GPCR-Targeting Antibody Discovery With AbCellera GPCR Events, Meetings, and Webinars GPCRs in drug discovery: challenges & solutions (June 19 - 23, 2023 - 4, 2023) NEW Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins

We will be back next week with our regular weekly GPCR news digest. In the meantime, you can always check the  Classified GPCR News from the last weeks. GPCR Podcast. GPCR. Today is also the first session of our hands-on workshop with Dr. Sam Hoare. GPCR University content coming soon.

November 2022 "Adhesion G-protein-coupled receptors (aGPCRs) play key roles in a diversity of physiologies A hallmark of aGPCR activation is the removal of the inhibitory GAIN domain and the dipping of the cleaved The structures also reveal the uncharted structural information of GPCR/G12 coupling. Taken together, our study lays the groundwork for understanding aGPCR activation and G-protein-coupling Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

Greetings GPCR enthusiasts! Join us to explore the fascinating world of GPCRs. GPCR Symposium on Structural and Molecular Insights on GPCR Activation. , CTO of Exscientia discuss transforming drug discovery using their AI-driven platform Salipro Biotech - 4, 2023) Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins GPCR Ecosystem

GPCR Symposium on Structural and Molecular Insights on GPCR Activation. GPCR Binders, Drugs, and more Molecular Characterization of Two Wamide Neuropeptide Signaling Systems Discovery and in vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins (March 24 GPCR Ecosystem

February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner announced that China’s National Medical Products Administration (NMPA) has accepted submission of a New Drug oliceridine) injection, a novel IV analgesic that has been approved in the United States by the Food and Drug Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available What a fun chat! GPCR Ecosystem paid membership to enjoy everything Dr. GPCR has! ➡️https://bit.ly/3TCJVQQ #gpcr #drgpcr

November 2022 "Recently determined structures of class C G protein-coupled receptors (GPCRs) revealed the location of allosteric binding sites and opened new opportunities for the discovery of novel modulators treatment of psychiatric and neurodegenerative diseases, and several allosteric modulators of this GPCR in complex with allosteric modulators can accelerate lead discovery." Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

Kenakin’s Emerging Drug Hunter  lecture delivers exclusive, cutting-edge insights that help you move This is about accelerating your path from discovery to clinic, without wasted cycles or missteps.     discovery, you know the pressure: timelines are tight, resources finite, and decisions must be fast The interpretation of high and low affinity binding sites  on GPCRs.   Unlock “Rethinking Affinity” Now Only in Terry's Corner _____ #GPCR #BindingAffinity #Pharmacology

Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE

Get ready to dive into some discoveries and mind-blowing breakthroughs with us! Paper with his team: Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China M Payne New ligands and new GPCR behaviors that produce unique drug profiles (i.e. intracellular ligands and November 21st : Unconventional GPCR Ligands as Drugs. 25 - 27, 2024 | 1st Virtual GPCR Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery

August 2022 "The cannabinoid CB1 receptor is the most abundant G protein coupled receptor (GPCR) in A variety of ligands for CB1 receptors have been developed as promising drug candidates for the treatment Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). " Read more at the source #DrGPCR #GPCR

signaling mechanisms by NMR spectroscopy with stable-isotope labeled receptors GPCR Binders, Drugs, worth up to $674M 2023 Half-Year Financial Results and Exciting Developments at Aelis Farma Ion Channel Drug Chair of its Board of Directors Novo Nordisk and Evotec collaborate to launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases GPCR Events, Meetings, Jobs NEW In vivo Antibody Discovery Research Scientist NEW In Vitro Biologist/Molecular Pharmacologist

Human cells express over 800 G-protein-coupled receptors (GPCRs) to facilitate communication with the Capturing the dynamics of GPCR activation has always been a challenge because G protein activation in With this high-resolution, dynamic view of GPCR activation, scientists can better tackle diseases by Beyond GPCRs, the methods and insights from this study can be applied to other fast, transient biological Time-resolved cryo-EM of G-protein activation by a GPCR. Nature (2024).

Check out some of the latest GPCR discoveries below! GPCR Binders, Drugs, and more Allosteric modulation of a human odorant receptor. Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells Reviews, GPCRs, and more G protein-coupled receptor-targeting antibody-drug conjugates: Current status Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery "Apr.19.2022 Ono Pharmaceutical Co., Ltd. Montréal (Québec, Canada; “UdM”), to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews

that the affinity of Fzd for Dvl was not affected by Wnt ligands, in contrast to other members of the GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Symposium on GPCR Activation and Signaling, May 19th, 2023. GPCR Binders, Drugs, and more Development of a 5-HT7 receptor antibody for the rat: the good, the bad Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development The pathway of opioid drugs Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem

Kenakin and Hoare on '   Applying Pharmacology to Drug Discovery ' and ' Advanced Data Analysis for GPCR ligands Key elements of a comprehensive and effective GPCR discovery strategy Exclusive 25% Early Bird behaviors for innovative drug profiles GPCR Event Highlight  11th Adhesion GPCR Workshop    Location GPCRs and mRNA antigens enable drug discovery and development Mapping GPCR-RAMP complexes with MolBoolean The value of GPCR cell-based assays in drug discovery October 2024 | Biologics US 2024   October 2 -

Binders, Drugs, and more The Leu/Val6.51 Side Chain of Cannabinoid Receptors Regulates the Binding Mode classifications and refinements in high-resolution single particle cryo-EM analysis Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron laser Deadline September 27, 2023 GPCR Events, Meetings, and Webinars September 25 - 28, 2023 | Discovery On Target September 27 - 28, 2023 | Training Seminar "The Renaissance in GPCRs as Drug Targets: Allosteric

Allosteric modulation of conserved motifs and helices in 5HT2BR: Advances drug discovery and therapeutic , Drugs, and more Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Application of computational methods for class A GPCR Ligand discovery. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. design PhD student at the Department of Drug Design and Pharmacology Computational drug design postdoc

GPCR Binders, Drugs, and more Development of a V5-tag-directed nanobody and its implementation as an GPCRs in Cardiology, Endocrinology, and Taste Insights on discovery, efficacy, safety and clinical applications Exscientia is the Sniper of the AI Drug Discovery Industry Indivior Announces Q2/H1 2023 Financial Results Symposium (September 7 - 8, 2023) Discovery On Target (September 25 - 28, 2023) ○ NEW Training Seminar , Discovery Toxicology Postdoc Fellow - Dr.

GPCR Symposium on GPCR Activation and Signaling held on May 19th, 2023. GPCR Binders, Drugs, and more Inhibiting a promiscuous GPCR: iterative discovery of bitter taste receptor Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem